Drug Trial Radar · NCT05651711
A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)
Last checked: Nov 19, 2026Latest source record: Jun 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
726
Actual
Start
Dec 14, 2022
Primary completion
Jun 5, 2024
Study completion Aug 27, 2024
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Dec 15, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The co-primary objectives of the study are to: * Evaluate the efficacy of rocatinlimab compared with placebo at Week 24, assessed using Validated Investigator's Global Assessment for Atopic Dermatitis (vIGA-AD). * Evaluate the efficacy of rocatinlimab compared with placebo at Week 24, assessed using Eczema Area and Severity Index (EASI).
Conditions
- Atopic Dermatitis
Interventions
RocatinlimabDrug
Rocatinlimab will be administered through a subcutaneous (SC) injection.
PlaceboOther
The matching placebo will be administered through a SC injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Who Achieved Validated Investigator's Global Assessment for AD (vIGA-AD) 1 Response With Presence of Only Barely Perceptible Erythema or vIGA-AD 0 Response (Revised Investigator's Global Assessment [rIGA] 0/1) at Week 24Time frame: Baseline and Week 24
- Number of Participants Who Achieved ≥ 75% Reduction From Baseline in Eczema Area and Severity Index Score (EASI 75) at Week 24Time frame: Baseline and Week 24
Locations
197 sites in 21 countries. Site status is shown where the registry gives one.
Research Solutions of Arizona, PC
Litchfield Park, Arizona
Center for Dermatology and Plastic Surgery
Scottsdale, Arizona
Clinical Trials Institute of Northwest Arkansas
Fayetteville, Arkansas
Burke Pharmaceutical Research
Hot Springs, Arkansas
Velocity Clinical Research Chula Vista
Chula Vista, California
West Coast Research LLC
Dublin, California
California Dermatology and Clinical Research Institute
Encinitas, California
Center for Dermatology Clinical Research Inc
Fremont, California
Velocity Clinical Research - San Diego
La Mesa, California
Velocity Clinical Research - North Hollywood
North Hollywood, California
Cura Clinical Research
Palmdale, California
University of California at San Francisco, Dermatology Clinic at Mount Zion
San Francisco, California
Clinical Science Institute
Santa Monica, California
Clarity Dermatology
Castle Rock, Colorado
Velocity Clinical Research - Denver
Denver, Colorado
Foxhall Research Center
Washington D.C., District of Columbia
Renaissance Research and Medical Group
Cape Coral, Florida
Driven Research LLC
Coral Gables, Florida
Saint Jude Clinical Research
Doral, Florida
Direct Helpers Research Center
Hialeah, Florida
Glick Skin Institute
Margate, Florida
Miami Dade Medical Research Institute, LLC
Miami, Florida
Innovation Medical Research Center Inc
Palmetto Bay, Florida
University of South Florida Health Morsani Center for Advanced Healthcare
Tampa, Florida
Advanced Medical Research PC
Sandy Springs, Georgia
Sneeze, Wheeze, and Itch Associates, LLC
Normal, Illinois
The South Bend Clinic LLP
South Bend, Indiana
Options Research Group LLC
West Lafayette, Indiana
Dermatology and Skin Cancer Center of Overland Park
Overland Park, Kansas
DS Research
Louisville, Kentucky
Kentucky Advanced Medical Research LLC
Murray, Kentucky
MetroBoston Clinical Partners
Brighton, Massachusetts
Wendy Sadoff MD Dermatology PC
Farmington Hills, Michigan
Revival Research Institute LLC
Troy, Michigan
Somerset Skin Centre
Troy, Michigan
Advanced Dermatology of the Midlands
Omaha, Nebraska
James Del Rosso Dermatology Research
Las Vegas, Nevada
Skin Cancer and Dermatology Institute
Reno, Nevada
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
Weiss Medical
Riverdale, New Jersey
Showing 40 of 197 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.